Skip to content
Menu
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Obalon Therapeutics, Inc. OBLN

Full chart Compare
Set alert

Price alert · OBLN

All alert types
3.05 +3.05

Quote time unavailable

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue by
Product → Revenue: $174.65KRevenue → Gross Profit: $218.77KGross Profit → Expenses: $218.77KRevenue → Cost of Revenue: $100.94KExpenses → Selling, General & Admin: $2.37MExpenses → Research & Development: $588.26KExpenses → Other Operating Expenses: $7.62MExpenses → Other Expenses: $126.09KLicense → Revenue: $116.90KNet Loss → Expenses: $10.48MRoyalty → Revenue: $28.17KGross Profit$218.77KNet Loss$10.48MCost of Revenue$100.94KExpenses$10.70MSelling, General & Admin$2.37MResearch & Development$588.26KOther Operating Expenses$7.62MOther Expenses$126.09KRevenue$319.71KProduct$174.65KLicense$116.90KRoyalty$28.17K

No annual statement lines

OBLN has no annual lines for this statement.